Tutorials
Guardant Health Inc logo

Guardant Health Inc

$ 50.12 +1.16 (+2.37%) 10:03 AM EST
P/E:
At Loss
P/B:
17.29
Market Cap:
$ 5.10B
Enterprise V:
$ 5.53B
Volume:
57.18K
Avg Vol (2M):
1.14M
Also Trade In:
Volume:
57.18K
Market Cap $:
5.10B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.14M
Enterprise Value $:
5.53B
PB Ratio:
17.29
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Guardant Health Inc
NAICS : 621511 SIC : 8071
505 Penobscot Drive, Redwood City, CA, USA, 94063
Description
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
Name Current Vs Industry Vs History
Cash-To-Debt 0.62
Equity-to-Asset 0.17
Debt-to-Equity 4.32
Debt-to-EBITDA -2.74
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.99
Distress
Grey
Safe
Beneish M-Score -0.77
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.35
9-Day RSI 46.88
14-Day RSI 50.29
6-1 Month Momentum % -33
12-1 Month Momentum % -55.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.18
Quick Ratio 5.83
Cash Ratio 5.09
Days Inventory 97.96
Days Sales Outstanding 70.06
Days Payable 68.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.8

Financials (Next Earnings Date:2022-11-04 Est.)

GH's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 408.13
EPS (TTM) ($) -5.41
Beta 0.94
Volatility % 55.69
14-Day RSI 50.29
14-Day ATR ($) 3.642969
20-Day SMA ($) 49.584
12-1 Month Momentum % -55.95
52-Week Range ($) 27.65 - 133.82
Shares Outstanding (Mil) 102.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Guardant Health Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More